Curcumin disturbs the TGF-β signaling in systemic scleroderma (SSc), by counteracted phosphorylation of Smad2 and induced upregulation of TGF-β-induced factor (TGIF)—a negative regulator of TGF-β signaling. Here, TGFB1 is linked to systemic sclerosis.